Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome study
Part of Bones, joints & muscles, Heart & circulation clinical trials.
This study looks at children with CACP syndrome, a rare genetic condition, to learn more about how the condition affects the body over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a clinical diagnosis of CACP syndrome that has been confirmed by genetic testing.
- You must have been diagnosed with CACP during childhood (before age 18).
- You must have been diagnosed between January 2005 and January 1, 2026.
- Your parent or legal guardian must give permission for you to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies children with inherited (genetic) heart conditions that started before age 16. It may help improve how doctors identify the genetic cause and understand which families are affected.
This study looks at people with certain inherited genetic conditions called RASopathies and their family members. It helps researchers understand these conditions and how genetic changes run in families, which may improve future care.
This study looks at calcium pyrophosphate deposition (CPPD) disease, which causes joint inflammation. It aims to understand the disease better by studying people with either an acute first episode or ongoing chronic CPPD arthritis.
This study collects information from children with a specific type of cerebral palsy called ataxic CP. It aims to better understand the condition, which could help improve future care.
This is an observational study that follows children under 18 with cardiomyopathy caused by certain MYBPC3 gene mutations. It aims to better understand how the disease changes over time, which may help future treatments be better targeted.
This study looks at the genetic causes of cerebral amyloid angiopathy (CAA), a condition where proteins build up in small brain blood vessels. It aims to better understand the disease and may help guide future treatments.
Hear when a new Arthropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.